Takuma Ikebuchi

Title: Takuma Ikebuchi: Innovator in Therapeutic Compounds

Introduction

Takuma Ikebuchi is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in developing compounds for treating central nervous system diseases. With a total of two patents to his name, Ikebuchi's work is recognized for its potential therapeutic benefits.

Latest Patents

Ikebuchi's latest patents include the dihydrate of a benzothiophene compound and a process for producing the same. The primary objective of this invention is to provide a compound that serves as a superior therapeutic agent for central nervous system diseases. Specifically, the invention details a dihydrate of 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy]-1H-quinolin-2-one or a salt thereof, along with the process for its production.

Career Highlights

Ikebuchi is currently employed at Otsuka Pharmaceutical Company, Limited, where he continues to innovate in the pharmaceutical sector. His work focuses on creating effective treatments that can improve patient outcomes in neurological health.

Collaborations

Throughout his career, Ikebuchi has collaborated with esteemed colleagues such as Hiroshi Yamashita and Tetsuya Sato. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Takuma Ikebuchi stands out as a dedicated inventor whose work in therapeutic compounds holds promise for addressing critical health challenges. His contributions to the field of pharmaceuticals are noteworthy and reflect his commitment to innovation.